Imipenem/Cilastatin/Relebactam Pharmacokinetics, Safety, and Outcomes in Adults and Adolescents With Cystic Fibrosis

Clinical trial NCT05561764 · TERMINATED

Trial details

NCT number: NCT05561764
Sponsor: Hartford Hospital
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Cystic Fibrosis Pneumonia, Bacterial

Start date: 2023-01-03
Primary completion: 2024-10-14
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.